Testing effectiveness (Phase 2)Not Yet RecruitingNCT03867487
What this trial is testing
SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease
Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNAFLDPediatric NAFLD
Justin Ryder 40